{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:34:52Z","timestamp":1792294492770,"version":"4.4.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ctim.2020.102402","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T20:55:04Z","timestamp":1588107304000},"page":"102402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Safety and pharmacokinetics of medical cannabis preparation in a monocentric series of young patients with drug resistant epilepsy"],"prefix":"10.1016","volume":"51","author":[{"given":"Marcella","family":"Gherzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Milano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Fucile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Calevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Margherita","family":"Mancardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lino","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Astuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Barco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Cangemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Manfredini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mattioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"De Grandis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctim.2020.102402_bib0005","first-page":"176","article-title":"Cannabinoids in pediatrics","volume":"22","author":"Campbell","year":"2017","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.ctim.2020.102402_bib0010","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pbb.2008.05.010","article-title":"Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures\u2014A short review","volume":"90","author":"Sv\u00ed\u017eensk\u00e1","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.ctim.2020.102402_bib0015","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s13311-015-0376-4","article-title":"Cannabis in the treatment of dystonia, dyskinesias, and tics","volume":"12","author":"Koppel","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ctim.2020.102402_bib0020","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/YIC.0000000000000126","article-title":"The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity","volume":"31","author":"Marinelli","year":"2016","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.ctim.2020.102402_bib0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","article-title":"Practical considerations in medical cannabis administration and dosing","volume":"49","author":"MacCallum","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ctim.2020.102402_bib0030","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ejpn.2016.07.021","article-title":"Effective treatment of spasticity using dronabinol in paediatric palliative care","volume":"20","author":"Kuhlen","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ctim.2020.102402_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2017-1818","article-title":"Medical cannabinoids in children and adolescents: a systematic review","volume":"140","author":"Wong","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.ctim.2020.102402_bib0040","first-page":"1","article-title":"Cannabis\u2010based products for pediatric epilepsy: a systematic review","volume":"00","author":"Elliott","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.ctim.2020.102402_bib0045","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctim.2020.102402_bib0050","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ctim.2020.102402_bib0055","first-page":"1","article-title":"Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence","volume":"0","author":"Stockings","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ctim.2020.102402_bib0060","series-title":"FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy","author":"US Food and Drug Administration","year":"2018"},{"key":"10.1016\/j.ctim.2020.102402_bib0065","series-title":"EMA\/143020\/2017. Committee for orphan medicinal products","author":"European Medicines Agency","year":"2017"},{"key":"10.1016\/j.ctim.2020.102402_bib0070","series-title":"EMA\/COMP\/557465\/2014. Committee for orphan medicinal products","author":"European Medicines Agency","year":"2014"},{"key":"10.1016\/j.ctim.2020.102402_bib0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.phrs.2016.03.005","article-title":"Cannabidiol and epilepsy: rationale and therapeutic potential","volume":"107","author":"Leo","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ctim.2020.102402_bib0080","unstructured":"Decreto 9.11.2015, Gazzetta Ufficiale della Repubblica Italiana, Serie Generale n.279, 30.11.2015."},{"key":"10.1016\/j.ctim.2020.102402_bib0085","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s00228-018-2516-3","article-title":"Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)\u2014A pilot study","volume":"74","author":"Pellesi","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ctim.2020.102402_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4155\/bio-2018-0184","article-title":"A UHPLC\u2013MS\/MS method for the quantification of \u0394 9-tetrahydrocannabinol and cannabidiol in decoctions and in plasma samples for therapeutic monitoring of medical cannabis","volume":"10","author":"Barco","year":"2018","journal-title":"Bioanalysis"},{"key":"10.1016\/j.ctim.2020.102402_bib0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yebeh.2017.07.014","article-title":"Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: pharmacological mechanisms, electroencephalographic profile, and brain cytokine levels","volume":"75","author":"Vilela","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.ctim.2020.102402_bib0100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11910-018-0882-y","article-title":"Cannabis for the treatment of epilepsy: an update","volume":"18","author":"Gaston","year":"2018","journal-title":"Curr Neurol Neurosci Rep"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229919316012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229919316012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:14:43Z","timestamp":1760807683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229919316012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":20,"alternative-id":["S0965229919316012"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2020.102402","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and pharmacokinetics of medical cannabis preparation in a monocentric series of young patients with drug resistant epilepsy","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2020.102402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102402"}}